Both in Biotechnology
Gilead Sciences vs Kymera Therapeutics
Over the past year GILD returned +41.9% and KYMR returned +127.4%; their daily moves had a correlation of 0.18.
GILD +41.9% KYMR +127.4%Growth of $1, one year, split-adjusted
| Metric | GILD | KYMR |
|---|---|---|
| Price | $174.48 | $136.25 |
| Market cap | $216.41B | $11.63B |
| Today | +4.19% | +7.21% |
| 1 month | +21.0% | +28.6% |
| 6 months | +28.0% | +58.0% |
| Year to date | +42.2% | +75.1% |
| 1 year | +43.0% | +128.1% |
| Revenue growth (YoY) | +6.8% | −100.0% |
| Gross margin | 81.1% | — |
| Net margin | 29.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.0× | 113.8× |
| Net cash | -$19.79B | $969.2M |
| Dividend yield | 1.88% | — |
| Volatility (60d) | 26.6% | 41.2% |
| Short % of float | 1.6% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).